Via Pharmaceuticals, Roche preclinical data

In rats, Via's Compound X showed a significant dose-dependent inhibition of body weight gain and reduction in fat pad size. The small molecule inhibitor of diacylglycerol O-acyltransferase-1 (DGAT1) ...